Renal Cancer

External Validation of Prognostic Models for Nonmetastatic Clear Cell Renal Cell Carcinoma in a Japanese Cohort: Evaluation of Predictive Performance. July 24, 2026

Overdiagnosis in Renal Cancer: The Hidden Consequence of Modern Imaging - Beyond the Abstract July 23, 2026

mTORC1 activation induces B7-H3-dependent metabolic reprogramming in renal cell carcinoma (RCC). July 23, 2026

Spatial distribution and prognostic significance of hemorrhagic imaging features in brain metastases from metastatic renal cell carcinoma. July 22, 2026

Immune checkpoint profiling of B7-H proteins predicts survival and treatment response in metastatic clear cell renal cell carcinoma. July 21, 2026

Iceball Margin < 5 mm Is Associated with Local Failure after CT-Guided Cryoablation of cT1a Renal Cell Carcinoma - Beyond the Abstract July 20, 2026

Fumarate hydratase-deficient renal cell carcinoma - results of the exploratory analysis in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line treatment. July 20, 2026

A Novel 7 Sialylation-Related LncRNA Signature as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma. July 17, 2026

Risk Stratification in Renal Cell Carcinoma: A Narrative Review. July 16, 2026

Integrative analysis prioritizes proteins associated with renal cell carcinoma and its risk factors. July 15, 2026

Predictive biomarkers for immunotherapy response in renal cell carcinoma: why have they failed? July 24, 2026

Early Intermittent Cabozantinib in Metastatic Renal Cell Carcinoma: Efficacy and Safety in a Multicenter Retrospective Analysis. July 23, 2026

Prognostic impact of adjacent organ invasion on cancer-specific mortality in non-metastatic renal cell carcinoma. July 22, 2026

Patient-Reported Outcome Design and Analysis in Randomized Controlled Trials of Renal Cell Carcinoma: A Systematic Review. July 21, 2026

Impact of robotic access and dedicated kidney surgery teams on nephron-sparing surgery for T1 renal masses: evidence from a Spanish multicenter registry. July 21, 2026

Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications. July 20, 2026

The Role of Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Carcinoma in the Era of Emerging Systemic Therapy: A Retrospective Cohort Study. July 17, 2026

Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma After Prior Therapy: Final Results from the Non-Interventional NORA Study. July 16, 2026

Mixed Response to Nivolumab Among Different Metastatic Sites in Patients With Metastatic Renal Cell Carcinoma: Incidence and Clinical Implications. July 15, 2026

First report of safety and outcomes of radiofrequency ablation of renal tumors using a new automated energy delivery-controlled system. July 14, 2026

Page 1 of 521